A. Küster

发表

Toxicity of the fluoroquinolone antibiotics enrofloxacin and ciprofloxacin to photoautotrophic aquatic organisms

Christoph Schlüter, I. Ebert, J. Bachmann, 2011, Environmental toxicology and chemistry.

Environmental risk assessment for the serotonin re‐uptake inhibitor fluoxetine: Case study using the European risk assessment framework

J. Parrott, M. Servos, T. Ternes, 2010, Integrated environmental assessment and management.

The CHMP guideline on environmental risk assessment of medicinal products for human use: Three years of regulatory experience

A. Küster, S. Hickmann, B. Rechenberg, 2009 .

A fluorescence-based bioassay for aquatic macrophytes and its suitability for effect analysis of non-photosystem II inhibitors

R. Altenburger, A. Küster, K. Pohl, 2007, Environmental science and pollution research international.

Light acclimation of photosynthesis in three charophyte species

H. Schubert, A. Küster, Ralf Schaible, 2004 .

Sex-specific light acclimation of Chara canescens (Charophyta)

H. Schubert, A. Küster, Ralf Schaible, 2005 .

Environmental risk assessment of ivermectin: A case study

Jörg Römbke, Ines Rönnefahrt, Elke Blübaum-Gronau, 2010, Integrated environmental assessment and management.

Pharmaceuticals in the environment: scientific evidence of risks and its regulation

Anette Küster, Nicole Adler, A. Küster, 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

Pharmaceuticals in the environment—Global occurrences and perspectives

Ina Ebert, Anette Küster, Silke Hickmann, 2016, Environmental toxicology and chemistry.

Regulatory demands on data quality for the environmental risk assessment of pharmaceuticals.

I. Ebert, J. Bachmann, A. Küster, 2009, Regulatory toxicology and pharmacology : RTP.

Light acclimation of the charophyte Lamprothamnium papulosum

H. Schubert, A. Küster, Ralf Schaible, 2000 .

Reporting and evaluation criteria as means towards a transparent use of ecotoxicity data for environmental risk assessment of pharmaceuticals.

C Rudén, M Breitholtz, M Ågerstrand, 2011, Environmental pollution.

Environmental risk assessment of human pharmaceuticals in the European Union: A case study with the β‐blocker atenolol

Jörg Römbke, Jeanne Garric, Thomas Knacker, 2010, Integrated environmental assessment and management.

Using the fish plasma model for comparative hazard identification for pharmaceuticals in the environment by extrapolation from human therapeutic data.

Rolf Altenburger, Anette Küster, Bettina Rechenberg, 2011, Regulatory toxicology and pharmacology : RTP.

Development and validation of a new fluorescence-based bioassay for aquatic macrophyte species.

Rolf Altenburger, Anette Küster, R. Altenburger, 2007, Chemosphere.

Berlin statement on legacy and emerging contaminants in polar regions.

Nikiforos A Alygizakis, C. D. de Wit, R. Ebinghaus, 2023, Chemosphere.

The international environmental specimen banks—let’s get visible

Rebecca S. Pugh, Anette Küster, Paul R. Becker, 2015, Environmental Science and Pollution Research.

In Response: A regulatory perspective on prioritization of emerging pollutants in the context of the Water Framework Directive

Anette Küster, C. Heiss, A. Küster, 2015, Environmental toxicology and chemistry.

Reporting and evaluation criteria as means towards a transparent use of ecotoxicity data for environmental risk assessment of pharmaceuticals.

C. Rudén, M. Breitholtz, I. Ebert, 2011, Environmental pollution.